Alerus Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,348
Closed -$298K 140
2018
Q1
$298K Sell
3,348
-27,086
-89% -$2.6M 0.04% 126
2017
Q4
$3.18M Buy
30,434
+1,174
+4% +$132K 0.45% 65
2017
Q3
$4.27M Sell
29,260
-452
-2% -$61.6K 0.62% 51
2017
Q2
$3.86M Sell
29,712
-98
-0.3% -$12K 0.57% 53
2017
Q1
$3.71M Sell
29,810
-3
-0% -$359 0.57% 52
2016
Q4
$3.45M Sell
29,813
-1,966
-6% -$219K 0.56% 53
2016
Q3
$3.32M Sell
31,779
-1,076
-3% -$116K 0.54% 56
2016
Q2
$3.24M Buy
+32,855
New +$3.4M 0.54% 57

Other funds holding CELG

Alerus Financial's CELG Position: Q2 2018 in Review

Alerus Financial sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 3,348 shares — an estimated $298K sold.

Alerus Financial first reported a position in CELG in Q2 2016 and held it in 8 quarters. The position peaked at $4.27M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Alerus Financial reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Alerus Financial sold 3,348 Celgene Corp shares in Q2 2018, an estimated $298K.
  • Alerus Financial first reported a position in Celgene Corp in Q2 2016 and held it in 8 quarters.
  • Alerus Financial's Celgene Corp position peaked at $4.27M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Alerus Financial's 13F filing for Q2 2018, filed 8 Aug 2018.